You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

 

Online download statistics by month:

Online download statistics by month: February 2022 to February 2026

AbstractFullPdf
Feb 2022618640192
Mar 2022702719415
Apr 2022264274131
May 202217317994
Jun 202217818398
Jul 202220220668
Aug 202223123691
Sep 202223523989
Oct 202217518270
Nov 202217117376
Dec 202216016072
Jan 202315115244
Feb 202316816971
Mar 202314714988
Apr 202314714866
May 202313013072
Jun 202313313782
Jul 2023269271113
Aug 202312812859
Sep 2023939430
Oct 202311811855
Nov 202315615770
Dec 202314014068
Jan 2024929363
Feb 202410010048
Mar 2024878764
Apr 2024798042
May 2024888948
Jun 2024818134
Jul 202410310440
Aug 202410610648
Sep 2024787945
Oct 202410911044
Nov 202412312652
Dec 202413013453
Jan 202510010042
Feb 202516516561
Mar 2025899041
Apr 202510110245
May 2025969765
Jun 2025586021
Jul 2025110
Feb 2026110
Total667667893070